Ethics of PET research in children

Pediatric PET Imaging

Volumn , Issue , 2006, Pages 72-91

  Munson, Suzanne ^a   Eshel, Neir ^b   Ernst, Monique ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42949176520     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-34641-4_7     Document Type: Chapter

References (65)

1. Ernst M. PET in child psychiatry: The risks and benefits of studying normal healthy children. Prog Neuropsychopharmacol Biol Psychiatry 1999;23(4): 561-570.
2. Biederman J, Faraone SV. Current concepts on the neurobiology of attention-deficit/hyperactivity disorder. J Atten Disord 2002;6(suppl 1): S7-S16.
3. Castellanos FX, Tannock R. Neuroscience of attention-deficit/ hyperactivity disorder: The search for endophenotypes. Nat Rev Neurosci 2002;3(8): 617-628.
4. Leung AK, Lemay JF. Attention deficit hyperactivity disorder: An update. Adv Ther 2003;20(6):305-318.
5. Daley KC. Update on attention-deficit/hyperactivity disorder. Curr Opin Pediatr 2004;16(2):217-226.
6. Ernst M, Zametkin AJ, Matochik JA et al. High midbrain (18F)DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 1999;156(8):1209-1215.
7. Ernst M, Zametkin AJ, Matochik JA et al. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A (fluorine-18)fluorodopa positron emission tomographic study. J Neurosci 1998;18(15):5901-5907.
8. Krause KH, Dresel SH, Krause J, et al. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2003;27(7):605-613.
9. Vitiello B, Jensen PS, Hoagwood K. Integrating science and ethics in child and adolescent psychiatry research. Biol Psychiatry 1999;46(8):1044-1049.
10. Ernst M, Rumsey J. Functional Neuroimaging in Child Psychiatry. Cambridge: Cambridge University Press, 2000.
11. Durston S, Hulshoff Pol HE, Casey BJ, et al. Anatomical MRI of the developing human brain: what have we learned? J Am Acad Child Adolesc Psychiatry 2001;40(9):1012-1020.
12. Giedd JN, Castellanos FX, Rajapakse JC, et al. Sexual dimorphism of the developing human brain. Prog Neuropsychopharmacol Biol Psychiatry 1997;21(8):1185-1201.
13. Chugani HT. A critical period of brain development: Studies of cerebral glucose utilization with PET. Prev Med 1998;27(2):184-188.
14. Castellanos FX, Elia J, Kruesi MJ, et al. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res 1994;52(3):305-316.
15. Shaywitz BA, Cohen DJ, Bowers MB Jr. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report. J Pediatr 1977;90(1):67-71.
16. Ernst M, Liebenauer LL, Tebeka D, et al. Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997;16(4):276-284.
17. Reimherr FW, Wender PH, Ebert MH, et al. Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in adults with attention deficit disorder, residual type. Psychiatry Res 1984;11(1):71-78.
18. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990;323(20): 1361-1366.
19. Ernst M, Cohen RM, Liebenauer LL, et al. Cerebral glucose metabolism in adolescent girls with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36(10):1399-1406.
20. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993;50(5):333-340.
21. Ambrosini PJ. A review of pharmacotherapy of major depression in children and adolescents. Psychiatr Serv 2000;51(5):627-633.
22. Leikin S. Minors' assent, consent, or dissent to medical research. IRB 1993;15(2):1-7.
23. Wendler D, Shah S. Should children decide whether they are enrolled in nonbeneficial research? Am J Bioeth 2003;3(4):1-7.
24. Wendler D, Shah S, Whittle A, et al. Nonbeneficial research with individuals who cannot consent: Is it ethically better to enroll healthy or affected individuals? IRB 2003;25(4):1-4.
25. Hinton VJ. Ethics of neuroimaging in pediatric development. Brain Cogn 2002;50(3):455-468.
26. Shastry BS. Molecular genetics of attention-deficit hyperactivity disorder (ADHD): An update. Neurochem Int 2004;44(7):469-474.
27. Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography study of human brain functional development. Ann Neurol 1987;22(4): 487-497.
28. Bentourkia M, Michel C, Ferriere G, et al. Evolution of brain glucose metabolism with age in epileptic infants, children and adolescents. Brain Dev 1998;20(7):524-529.
29. Chugani HT, Phelps ME. Imaging human brain development with positron emission tomography. J Nucl Med 1991;32(1):23-26.
30. Rosa Neto P, Lou H, Cumming P, et al. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Ann N Y Acad Sci 2002;965: 434-439.
31. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283(20):2701-2711.
32. Ernst M, Freed ME, Zametkin AJ. Health hazards of radiation exposure in the context of brain imaging research: Special consideration for children. J Nucl Med 1998;39(4):689-698.
33. Ron E, Modan B, Preston D, et al. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 1989;120(3):516-531.
34. Juven Y, Sadetzki S. A possible association between ionizing radiation and pituitary adenoma: A descriptive study. Cancer 2002;95(2):397-403.
35. Billen D. Spontaneous DNA damage and its significance for the "negligible dose" controversy in radiation protection. Radiat Res 1990;124(2):242-245.
36. Sanderson BJ, Morley AA. Exposure of human lymphocytes to ionizing radiation reduces mutagenesis by subsequent ionizing radiation. Mutat Res 1986;164(6):347-351.
37. Kelsey KT, Memisoglu A, Frenkel D, et al. Human lymphocytes exposed to low doses of X-rays are less susceptible to radiation-induced mutagenesis. Mutat Res 1991;263(4):197-201.
38. Arnold LE, Zametkin AJ, Caravella L, Korbly N. Ethical Issues in Neuroimaging Research with Children. In: Ernst M, Rumsey JM, eds. Functional Neuroimaging in Child Psychiatry. Cambridge: Cambridge University Press, 2000:99-109.
39. Arnold LE, Stoff DM, Cook E Jr, et al. Ethical issues in biological psychiatric research with children and adolescents. J Am Acad Child Adolesc Psychiatry 1995;34(7):929-939.
40. Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002;159(1):36-42.
41. King NM. Defining and describing benefit appropriately in clinical trials. J Law Med Ethics 2000;28(4):332-343.
42. U.S. Department of Health and Human Services. Protection of Human Subjects. 45 CFR §46. 2001.
43. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: U.S. Government Printing Office, 1979.
44. Austin Radiological Association. Radiation Safety and Medical Imaging. 2004. http://www.ausrad.com/rse-le-p-radsafe.shtml.
45. Shah S, Whittle A, Wilfond B, et al. How do institutional review boards apply the federal risk and benefit standards for pediatric research? JAMA 2004;291(4):476-482.
46. Office for the Protection from Research Risks. Protecting Human Research Subjects: Institutional Review Board Guidebook. Washington DC: U.S. Government Printing Office, 1993.
47. McWilliams R, Hoover-Fong J, Hamosh A, et al. Problematic variation in local institutional review of a multicenter genetic epidemiology study. JAMA 2003;290(3):360-366.
48. Rogers AS, Schwartz DF, Weissman G, et al. A case study in adolescent participation in clinical research: eleven clinical sites, one common protocol, and eleven IRBs. IRB 1999;21(1):6-10.
49. Nicholson R. Medical Research with Children: Ethics, Law, and Practice. Oxford: Oxford University Press, 1986.
50. Gilsanz V, Roe TF, Mora S, et al. Changes in vertebral bone density in black girls and white girls during childhood and puberty. N Engl J Med 1991;325(23):1597-1600.
51. Meeting of the National Human Research Protections Advisory Committee. The meeting was held in Washington, DC, 2002.
52. Alexander D. Regulation of research with children: The evolution from exclusion to inclusion. J Health Care Law Policy 2002;6(1):1-13.
53. Whittle A, Shah S, Wilfond B, et al. Institutional review board practices regarding assent in pediatric research. Pediatrics 2004;113(6):1747-1752.
54. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001;40(2):147-158.
55. Radiation Safety Committee NIH. Improving Informed Consent for Research Radiation Studies. 2001. http://www.nih.gov/od/ors/ds/rsb/rsc/forms/informed- consent.pdf.
56. Baylis F. Mandating research with children. IRB 1999;21(1):10-11.
57. National Institutes of Health. NIH Policy and Guidelines on the Inclusion of Children as Participants in Research Involving Human Subjects. 1998. http://grans2.nih.gov/grants/guide/notice-files/not98-024.html.
58. Center for Drug Evaluation and Research and US Food and Drug Administration. Offices of Drug Evaluation Statistical Report 89-233530. Rockville, MD: U.S. Department of Health and Human Services, 1989.
59. Ericka Grimes v. Kennedy Krieger Institute, Inc. August 16, 2001. Maryland Court of Appeals.
60. Nelson RM. Nontherapeutic research, minimal risk, and the Kennedy Krieger lead abatement study. IRB 2001;23(6):7-11.
61. Sharav VH. Children in clinical research: A conflict of moral values. Am J Bioeth 2003;3(1):W-IF.
62. Mastroianni AC, Kahn JP. Risk and responsibility: ethics, Grimes v Kennedy Krieger, and public health research involving children. Am J Public Health 2002;92(7):1073-1076.
63. Wendler D, Forster H. Why we need legal standards for pediatric research. J Pediatr 2004;144(2):150-153.
64. Dawanna Robertson, J. Michael McGee, MD, et al. January 29, 2001. U.S. District Court in Tulsa, Okla.
65. Anderlik MR, Elster N. Lawsuits against IRBs: Accountability or incongruity? J Law Med Ethics 2001;29(2):220-228.